4D Molecular Therapeutics (FDMT) Stock Chart & Stock Price History $4.92 +0.21 (+4.34%) As of 03:19 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends 4D Molecular Therapeutics Stock Price Performance 5 Day Performance-11.36%1 Month Performance+8.44%3 Month Performance-34.01%6 Month Performance-63.33%Year-To-Date Performance-4.99%1 Year Performance-80.97% Receive FDMT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for 4D Molecular Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address FDMT Stock Chart for Friday, February, 14, 2025 FDMT Chart by TradingView 4D Molecular Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/13/2025$4.55$4.72+3.74%$4.77$4.511.36 million shs$218.21 million02/12/2025$4.58$4.55-0.66%$4.67$4.411.10 million shs$210.34 million02/11/2025$5.32$4.58-13.91%$5.27$4.571.24 million shs$211.73 million02/10/2025$5.97$5.32-10.89%$6.11$5.271.56 million shs$245.94 million02/07/2025$6.52$5.97-8.44%$6.77$5.962.07 million shs$275.99 million02/06/2025$6.14$6.52+6.19%$6.91$6.041.49 million shs$301.42 million02/05/2025$5.92$6.14+3.72%$6.26$5.95582,262 shs$283.85 million02/04/2025$5.93$5.92-0.17%$6.02$5.542.10 million shs$273.68 million02/03/2025$5.60$5.93+5.89%$5.94$5.291.10 million shs$274.14 million01/31/2025$5.60$5.60$5.64$5.30851,450 shs$258.88 million Get the Latest News and Ratings for FDMT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for 4D Molecular Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 01/30/2025$5.00$5.60+12.00%$5.65$4.97914,611 shs$258.89 million01/29/2025$4.65$5.00+7.53%$5.03$4.60617,359 shs$231.15 million01/28/2025$4.72$4.65-1.48%$4.74$4.50379,761 shs$214.97 million01/27/2025$4.66$4.72+1.29%$4.96$4.63467,879 shs$218.21 million01/24/2025$4.87$4.66-4.31%$4.88$4.64343,091 shs$215.43 million01/23/2025$4.61$4.87+5.64%$4.88$4.43551,571 shs$225.14 million01/22/2025$4.67$4.61-1.28%$4.80$4.49413,597 shs$213.12 million01/21/2025$4.58$4.67+1.97%$4.69$4.481.12 million shs$215.89 million01/20/2025$4.58$4.58$4.73$4.50927,608 shs$211.73 million01/17/2025$4.68$4.58-2.14%$4.73$4.50927,608 shs$211.73 million01/16/2025$5.04$4.68-7.14%$5.01$4.63522,876 shs$216.36 million01/15/2025$4.88$5.04+3.28%$5.15$4.87626,938 shs$232.99 million01/14/2025$4.76$4.88+2.52%$5.09$4.80629,471 shs$225.59 million01/13/2025$5.52$4.76-13.77%$5.31$4.681.37 million shs$220.05 million Related Companies COLL Stock Price Chart COGT Stock Price Chart ZYME Stock Price Chart NTLA Stock Price Chart PHVS Stock Price Chart RCKT Stock Price Chart IMNM Stock Price Chart REPL Stock Price Chart ABCL Stock Price Chart AVBP Stock Price Chart Receive FDMT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for 4D Molecular Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:FDMT) was last updated on 2/14/2025 by MarketBeat.com Staff From Our Partners*Breaking News!* This Pharma NASDAQ Company and the U.S Army!!! This Little Known NASDAQ Company just released positive results from its drugs that have been undergoing testi...Trading Wire | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredElon’s #1 investment during Trump’s termWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredTrump Policies Are Going to Light a Fire Under GoldHow You Can Profit from Trump's Bold Moves in 2025 Donald Trump’s bold policies are creating unprecedented ...Golden Portfolio | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 4D Molecular Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 4D Molecular Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.